Published in Prion on January 10, 2009
Dimer formation enhances structural differences between amyloid β-protein (1-40) and (1-42): an explicit-solvent molecular dynamics study. PLoS One (2012) 1.01
α-Synuclein misfolding assessed with single molecule AFM force spectroscopy: effect of pathogenic mutations. Biochemistry (2013) 0.89
Nanoimaging for prion related diseases. Prion (2010) 0.87
Discrete molecular dynamics study of oligomer formation by N-terminally truncated amyloid β-protein. J Mol Biol (2013) 0.86
Nanoprobing of misfolding and interactions of amyloid β 42 protein. Nanomedicine (2013) 0.82
Potential sources of interference on Abeta immunoassays in biological samples. Alzheimers Res Ther (2012) 0.75
Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers (1983) 99.69
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Alzheimer's disease: the amyloid cascade hypothesis. Science (1992) 13.80
A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A (2002) 9.55
Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science (2005) 8.86
Interfaces and the driving force of hydrophobic assembly. Nature (2005) 8.54
Pathways to a protein folding intermediate observed in a 1-microsecond simulation in aqueous solution. Science (1998) 8.46
Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry (2006) 6.54
Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci (2004) 5.10
A revised set of potentials for beta-turn formation in proteins. Protein Sci (1994) 4.97
Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem (1999) 4.64
Helix to helix packing in proteins. J Mol Biol (1981) 4.24
In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem (2002) 4.20
Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J Neurosci Res (2002) 3.79
Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol (2001) 3.46
Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J Mol Biol (2001) 3.26
Dissecting the assembly of Abeta16-22 amyloid peptides into antiparallel beta sheets. Structure (2003) 3.18
Progress towards a molecular-level structural understanding of amyloid fibrils. Curr Opin Struct Biol (2004) 2.92
Left-handed polyproline II helices commonly occur in globular proteins. J Mol Biol (1993) 2.62
On the nucleation of amyloid beta-protein monomer folding. Protein Sci (2005) 2.47
Preformed structural elements feature in partner recognition by intrinsically unstructured proteins. J Mol Biol (2004) 2.44
Methods for molecular dynamics simulations of protein folding/unfolding in solution. Methods (2004) 2.30
The Alzheimer's peptide a beta adopts a collapsed coil structure in water. J Struct Biol (2000) 2.26
Folding-unfolding thermodynamics of a beta-heptapeptide from equilibrium simulations. Proteins (1999) 2.25
Calculations on folding of segment B1 of streptococcal protein G. J Mol Biol (1998) 2.19
A survey of flexible protein binding mechanisms and their transition states using native topology based energy landscapes. J Mol Biol (2005) 1.99
Amyloid beta-protein monomer structure: a computational and experimental study. Protein Sci (2006) 1.99
Molecular dynamics simulations of Alzheimer's beta-amyloid protofilaments. J Mol Biol (2005) 1.99
Relationship between ion pair geometries and electrostatic strengths in proteins. Biophys J (2002) 1.91
Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores. J Mol Biol (2003) 1.81
Elucidating amyloid beta-protein folding and assembly: A multidisciplinary approach. Acc Chem Res (2006) 1.80
Pathogenic effects of D23N Iowa mutant amyloid beta -protein. J Biol Chem (2001) 1.74
The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation. Protein Sci (2005) 1.74
Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem (2000) 1.71
Simulations as analytical tools to understand protein aggregation and predict amyloid conformation. Curr Opin Chem Biol (2006) 1.70
Repacking protein cores with backbone freedom: structure prediction for coiled coils. Proc Natl Acad Sci U S A (1995) 1.64
Molecular dynamics simulation of amyloid beta dimer formation. Biophys J (2004) 1.63
Familial Alzheimer's disease mutations alter the stability of the amyloid beta-protein monomer folding nucleus. Proc Natl Acad Sci U S A (2007) 1.55
Insights into the amyloid folding problem from solid-state NMR. Biochemistry (2003) 1.54
Structure of the 21-30 fragment of amyloid beta-protein. Protein Sci (2006) 1.51
A seven-helix coiled coil. Proc Natl Acad Sci U S A (2006) 1.48
Realistic simulations of native-protein dynamics in solution and beyond. Annu Rev Biophys Biomol Struct (1993) 1.46
Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution. Biophys J (2001) 1.45
Folding events in the 21-30 region of amyloid beta-protein (Abeta) studied in silico. Proc Natl Acad Sci U S A (2005) 1.43
Linking folding with aggregation in Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci U S A (2007) 1.42
The structure of the Alzheimer amyloid beta 10-35 peptide probed through replica-exchange molecular dynamics simulations in explicit solvent. J Mol Biol (2006) 1.42
Assessing equilibration and convergence in biomolecular simulations. Proteins (2002) 1.40
Solvent and mutation effects on the nucleation of amyloid beta-protein folding. Proc Natl Acad Sci U S A (2005) 1.37
Aqueous urea solution destabilizes Abeta(16-22) oligomers. Proc Natl Acad Sci U S A (2004) 1.34
A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils. Nat Struct Biol (2000) 1.31
Standard structures in proteins. Prog Biophys Mol Biol (1993) 1.28
Conformational transition of amyloid beta-peptide. Proc Natl Acad Sci U S A (2005) 1.28
Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red. J Neurosci Res (1999) 1.27
Protein interactions and misfolding analyzed by AFM force spectroscopy. J Mol Biol (2005) 1.23
Temperature-dependent beta-sheet formation in beta-amyloid Abeta(1-40) peptide in water: uncoupling beta-structure folding from aggregation. Biochim Biophys Acta (2000) 1.22
Role of electrostatic interactions in amyloid beta-protein (A beta) oligomer formation: a discrete molecular dynamics study. Biophys J (2007) 1.22
Long timescale simulations. Curr Opin Struct Biol (2000) 1.20
Charge states rather than propensity for beta-structure determine enhanced fibrillogenesis in wild-type Alzheimer's beta-amyloid peptide compared to E22Q Dutch mutant. Protein Sci (2002) 1.19
Charge alterations of E22 enhance the pathogenic properties of the amyloid beta-protein. J Neurochem (2000) 1.18
Kinetics of peptide folding: computer simulations of SYPFDV and peptide variants in water. J Mol Biol (1997) 1.18
Nanomedicine and protein misfolding diseases. Nanomedicine (2005) 1.11
Beta-hairpin conformation of fibrillogenic peptides: structure and alpha-beta transition mechanism revealed by molecular dynamics simulations. Proteins (2004) 1.09
A strand-loop-strand structure is a possible intermediate in fibril elongation: long time simulations of amyloid-beta peptide (10-35). J Am Chem Soc (2005) 1.07
Nanoimaging for protein misfolding and related diseases. J Cell Biochem (2006) 1.05
Computer simulations of Alzheimer's amyloid beta-protein folding and assembly. Curr Alzheimer Res (2006) 1.04
Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide. Biophys J (2006) 1.04
Structures and free-energy landscapes of the wild type and mutants of the Abeta(21-30) peptide are determined by an interplay between intrapeptide electrostatic and hydrophobic interactions. J Mol Biol (2008) 1.01
Influence of the solvent structure on the electrostatic interactions in proteins. Biophys J (2004) 0.95
Stabilization of discordant helices in amyloid fibril-forming proteins. Protein Sci (2004) 0.95
Misfolding of the amyloid beta-protein: a molecular dynamics study. Proteins (2006) 0.94
Simulation study on the disordered state of an Alzheimer's beta amyloid peptide Abeta(12 36) in water consisting of random-structural, beta-structural, and helical clusters. Protein Sci (2007) 0.91
The effect of Abeta conformation on the metal affinity and aggregation mechanism studied by circular dichroism spectroscopy. J Biochem (2006) 0.91
Structural analysis of peptide substrates for mucin-type O-glycosylation. Biochemistry (1998) 0.87
Dissection of the de novo designed peptide alpha t alpha: stability and properties of the intact molecule and its constituent helices. Biochemistry (1999) 0.87
Strategies and rationales for the de novo design of a helical hairpin peptide. Protein Sci (1995) 0.83
Complementary packing of alpha-helices in proteins. FEBS Lett (1999) 0.82
Temperature-induced conformational changes in amyloid beta(1-40) peptide investigated by simultaneous FT-IR microspectroscopy with thermal system. Biophys Chem (2001) 0.81
A linear 23-residue peptide reveals a propensity to form an unusual native-like conformation. J Biomol Struct Dyn (1995) 0.76
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med (2007) 5.65
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol (2004) 2.20
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Res (2007) 2.06
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. J Clin Invest (2011) 2.01
Silatrane-based surface chemistry for immobilization of DNA, protein-DNA complexes and other biological materials. Ultramicroscopy (2003) 2.01
Full-length dominant-negative survivin for cancer immunotherapy. Clin Cancer Res (2003) 2.00
Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons. PLoS One (2008) 1.99
Unpaired structures in SCA10 (ATTCT)n.(AGAAT)n repeats. J Mol Biol (2003) 1.87
Regulation of poly(ADP-ribose) polymerase-1 by DNA structure-specific binding. J Biol Chem (2005) 1.76
Clostridium taeniosporum spore ribbon-like appendage structure, composition and genes. Mol Microbiol (2007) 1.58
Atomic force microscopy studies provide direct evidence for dimerization of the HIV restriction factor APOBEC3G. J Biol Chem (2010) 1.38
Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer. Breast Cancer Res Treat (2015) 1.37
Triplet repeat DNA structures and human genetic disease: dynamic mutations from dynamic DNA. J Biosci (2002) 1.37
Dynamics of nucleosomes revealed by time-lapse atomic force microscopy. Biochemistry (2009) 1.30
Single-molecule atomic force microscopy force spectroscopy study of Aβ-40 interactions. Biochemistry (2011) 1.30
Protein interactions and misfolding analyzed by AFM force spectroscopy. J Mol Biol (2005) 1.23
Specific binding of poly(ADP-ribose) polymerase-1 to cruciform hairpins. J Mol Biol (2005) 1.22
Forcing nonamyloidogenic beta-synuclein to fibrillate. Biochemistry (2005) 1.19
Dynamics of nucleosomes assessed with time-lapse high-speed atomic force microscopy. Biochemistry (2011) 1.18
"Antiparallel" DNA loop in gal repressosome visualized by atomic force microscopy. J Mol Biol (2003) 1.17
DNA strand arrangement within the SfiI-DNA complex: atomic force microscopy analysis. Biochemistry (2006) 1.16
alpha-Synuclein misfolding: single molecule AFM force spectroscopy study. J Mol Biol (2008) 1.16
Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors. J Immunother (2007) 1.13
Nanomedicine and protein misfolding diseases. Nanomedicine (2005) 1.11
Holliday junction dynamics and branch migration: single-molecule analysis. Proc Natl Acad Sci U S A (2005) 1.10
Early stages for Parkinson's development: alpha-synuclein misfolding and aggregation. J Neuroimmune Pharmacol (2008) 1.09
Effects of nitration on the structure and aggregation of alpha-synuclein. Brain Res Mol Brain Res (2005) 1.09
Probing Interactions within the synaptic DNA-SfiI complex by AFM force spectroscopy. J Mol Biol (2006) 1.07
A novel approach for analysis of the log-linear age-period-cohort model: application to lung cancer incidence. Cancer Inform (2009) 1.07
Mapping nucleosome locations on the 208-12 by AFM provides clear evidence for cooperativity in array occupation. Biochemistry (2002) 1.07
Nanoimaging for protein misfolding and related diseases. J Cell Biochem (2006) 1.05
Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85. Mol Pharm (2006) 1.05
Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket. J Pharmacol Exp Ther (2005) 1.03
A Generalized Beta model for the age distribution of cancers: application to pancreatic and kidney cancer. Cancer Inform (2009) 1.03
Supercoiling-induced DNA bending. Biochemistry (2004) 1.03
Effect of spermidine on misfolding and interactions of alpha-synuclein. PLoS One (2012) 1.03
Molecular mechanism underlying RAG1/RAG2 synaptic complex formation. J Biol Chem (2009) 1.03
Direct visualization of the EcoRII-DNA triple synaptic complex by atomic force microscopy. Biochemistry (2007) 1.02
Effect of DNA supercoiling on the geometry of holliday junctions. Biochemistry (2006) 1.02
DNA recombination: holliday junctions dynamics and branch migration. J Biol Chem (2003) 1.01
The role of histone H4 biotinylation in the structure of nucleosomes. PLoS One (2011) 1.01
Molecular mechanism of misfolding and aggregation of Aβ(13-23). J Phys Chem B (2013) 1.01
Nanoscale structure and dynamics of ABOBEC3G complexes with single-stranded DNA. Biochemistry (2012) 1.00
Nanoprobing of α-synuclein misfolding and aggregation with atomic force microscopy. Nanomedicine (2010) 1.00
DNA synapsis through transient tetramerization triggers cleavage by Ecl18kI restriction enzyme. Nucleic Acids Res (2010) 0.99
The role of the SEA (sea urchin sperm protein, enterokinase and agrin) module in cleavage of membrane-tethered mucins. FEBS J (2005) 0.98
Mica functionalization for imaging of DNA and protein-DNA complexes with atomic force microscopy. Methods Mol Biol (2013) 0.98
DNA topology and geometry in Flp and Cre recombination. J Mol Biol (2006) 0.98
Interaction of the Zalpha domain of human ADAR1 with a negatively supercoiled plasmid visualized by atomic force microscopy. Nucleic Acids Res (2004) 0.98
Effects of notch signaling on regulation of myeloid cell differentiation in cancer. Cancer Res (2013) 0.97
Estimation of hazard functions in the log-linear age-period-cohort model: application to lung cancer risk associated with geographical area. Cancer Inform (2010) 0.96
Physicochemically tunable polyfunctionalized RNA square architecture with fluorogenic and ribozymatic properties. ACS Nano (2014) 0.96
Effect of electrostatics on aggregation of prion protein Sup35 peptide. J Phys Condens Matter (2012) 0.96
A heuristic solution of the identifiability problem of the age-period-cohort analysis of cancer occurrence: lung cancer example. PLoS One (2012) 0.96
Site-specific labeling of supercoiled DNA at the A+T rich sequences. Biochemistry (2002) 0.95
Weibull-like Model of Cancer Development in Aging. Cancer Inform (2010) 0.95
Novel polymer linkers for single molecule AFM force spectroscopy. Methods (2013) 0.95
Influence of the solvent structure on the electrostatic interactions in proteins. Biophys J (2004) 0.95
Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study. Am J Gastroenterol (2012) 0.93
Specificity of binding of single-stranded DNA-binding protein to its target. Biochemistry (2012) 0.93
Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs. BMC Immunol (2004) 0.93
Structure, dynamics, and branch migration of a DNA Holliday junction: a single-molecule fluorescence and modeling study. Biophys J (2008) 0.92
Intersegmental interactions in supercoiled DNA: atomic force microscope study. Ultramicroscopy (2003) 0.92
Mechanism of amyloid β-protein dimerization determined using single-molecule AFM force spectroscopy. Sci Rep (2013) 0.92
Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes. Mol Immunol (2008) 0.91
Atomic force microscopy analysis of the Huntington protein nanofibril formation. Nanomedicine (2005) 0.91
Comment re: Cancer incidence falls for oldest. Cancer Res (2009) 0.89
Nanoprobing of the effect of Cu(2+) cations on misfolding, interaction and aggregation of amyloid β peptide. J Neuroimmune Pharmacol (2012) 0.89
Influence of global DNA topology on cruciform formation in supercoiled DNA. J Mol Biol (2004) 0.89
Basic equations and computing procedures for frailty modeling of carcinogenesis: application to pancreatic cancer data. Cancer Inform (2013) 0.89
α-Synuclein misfolding assessed with single molecule AFM force spectroscopy: effect of pathogenic mutations. Biochemistry (2013) 0.89
Atomic force microscopy studies of APOBEC3G oligomerization and dynamics. J Struct Biol (2013) 0.88
Breast cancer incidence in black and white women stratified by estrogen and progesterone receptor statuses. PLoS One (2012) 0.88
Site-specific labeling of supercoiled DNA. Nucleic Acids Res (2006) 0.87
Dynamics of synaptic SfiI-DNA complex: single-molecule fluorescence analysis. Biophys J (2007) 0.87
Nanoimaging for prion related diseases. Prion (2010) 0.87
Interarm interaction of DNA cruciform forming at a short inverted repeat sequence. Biophys J (2003) 0.86
Atomic force microscopy study of the effects of Mg(2+) and other divalent cations on the end-to-end DNA interactions. Biochemistry (2002) 0.86
Evaluation of the influence of the internal aqueous solvent structure on electrostatic interactions at the protein-solvent interface by nonlocal continuum electrostatic approach. Biopolymers (2007) 0.85
Assembly of the SLIP1-SLBP complex on histone mRNA requires heterodimerization and sequential binding of SLBP followed by SLIP1. Biochemistry (2013) 0.85
Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi. J Proteome Res (2006) 0.85
Quantitative analyses of RAG-RSS interactions and conformations revealed by atomic force microscopy. Biochemistry (2008) 0.85
Single-molecule dynamics of the DNA-EcoRII protein complexes revealed with high-speed atomic force microscopy. Biochemistry (2009) 0.85
Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human prostate cancer cell line model. Urol Oncol (2004) 0.85
Single molecule fluorescence analysis of branch migration of holliday junctions: effect of DNA sequence. Biophys J (2008) 0.84
Single-molecule selection and recovery of structure-specific antibodies using atomic force microscopy. Nanomedicine (2007) 0.84
Visual analysis of concerted cleavage by type IIF restriction enzyme SfiI in subsecond time region. Biophys J (2011) 0.83
Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer. BMC Cancer (2014) 0.82
Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses. Glycobiology (2005) 0.82
Structural heterogeneity of pyrimidine/purine-biased DNA sequence analyzed by atomic force microscopy. Eur J Biochem (2002) 0.82
Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core. Glycobiology (2003) 0.82
Hyaluronan conformations on surfaces: effect of surface charge and hydrophobicity. Carbohydr Res (2005) 0.82
Suitability of stratagene reference RNA for analysis of lymphoid tissues. Biotechniques (2004) 0.81
Sperm chromatin released by nucleases. Syst Biol Reprod Med (2008) 0.81
T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1. Int Immunopharmacol (2005) 0.80
Atomic force microscopy analysis of the Huntington protein nanofibril formation. Dis Mon (2005) 0.80
Identification of disulfide bonds among the nine core 2 N-acetylglucosaminyltransferase-M cysteines conserved in the mucin beta6-N-acetylglucosaminyltransferase family. J Biol Chem (2004) 0.80
From bench to bedside: successful translational nanomedicine: highlights of the Third Annual Meeting of the American Academy of Nanomedicine. Nanomedicine (2007) 0.80
Nucleosomes structure and dynamics: effect of CHAPS. Int J Biochem Mol Biol (2011) 0.79
Prognostic estimator of survival for patients with localized and extended pancreatic ductal adenocarcinoma. Cancer Inform (2013) 0.77